Hormone withdrawal-associated symptoms with ethinylestradiol 20 μg/drospirenone 3 mg (24/4 regimen) versus ethinylestradiol 20 μg/desogestrel 150 μg (21/7 regimen)

OBJECTIVE: To assess whether the combined oral contraceptive (COC) ethinylestradiol (EE) 20 μg/drospirenone 3 mg taken in a 24/4-day regimen (ie, 4-day hormone-free interval) is more effective than an EE 20 μg/desogestrel (DSG) 150 μg COC taken in a 21/7-day regimen (ie, 7-day hormone-free interval)...

Descripción completa

Detalles Bibliográficos
Autores principales: Bitzer, Johannes, Banal-Silao, Maria Jesusa, Ahrendt, Hans-Joachim, Restrepo, Jaime, Hardtke, Marion, Wissinger-Graefenhahn, Ulrike, Trummer, Dietmar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445871/
https://www.ncbi.nlm.nih.gov/pubmed/26056491
http://dx.doi.org/10.2147/IJWH.S77942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445871/
https://www.ncbi.nlm.nih.gov/pubmed/26056491
http://dx.doi.org/10.2147/IJWH.S77942

Ejemplares similares